Prostaglandin E1 transported into cells blocks the apoptotic signals induced by nerve growth factor deprivation

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 1907-1914

  Kawamura, Toru ^a   Horie, Satoshi ^a   Maruyama, Tomoyuki ^a   Akira, Toshiaki ^a,b   Imagawa, Takashi ^a   Nakamura, Norifumi ^a  

^a Pharmaceutical Research Division   (Japan)

^b NONE   (Japan)

Author keywords

Apoptosis; Nerve growth factor deprivation Prostaglandin transporter; PC12 cells; Prostaglandin E1

Indexed keywords

COMPLEMENTARY DNA; NERVE GROWTH FACTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STRESS ACTIVATED PROTEIN KINASE; ANTIPORTER; CYCLIC AMP; DNA BINDING PROTEIN; ORGANIC ANION TRANSPORTER; PROTEIN KINASE (CALCIUM,CALMODULIN); SLCO2A1 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; NERVE CELL NECROSIS; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; ANIMAL; CELL DIFFERENTIATION; CELL STRAIN; DRUG ANTAGONISM; DRUG EFFECT; INTRACELLULAR MEMBRANE; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ALPROSTADIL; ANIMALS; ANTIPORTERS; APOPTOSIS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CYCLIC AMP; DNA-BINDING PROTEINS; INTRACELLULAR MEMBRANES; NERVE GROWTH FACTORS; NEURONS; ORGANIC ANION TRANSPORTERS; PC12 CELLS; RATS; SIGNAL TRANSDUCTION;

EID: 0032589034     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721907.x     Document Type: Article

References (43)

1. Adams M., Rejinato M. J., Shao D., Lazar M. A., and Chatterjee V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132.
2. Alok D., Boyadjieva N. I., Pastorcic M., Reddy B. V., and Sarkar D. K. (1994) Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic β-endorphin neurons. J. Biol. Chem. 269, 26697-26705.
3. Bradshaw M. A. (1978) Nerve growth factor. Annu. Rev. Biochem. 47, 191-216.
4. Burkey T. H. and Regan J. W. (1995) Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem. Biophys. Res. Commun. 211, 152-158.
5. Chen Y. R., Meyer C. F., and Tan T. H. (1996a) Persistent activation of c-Jun N-terminal kinase 1 (JNKI) in gamma radiation-induced apoptosis. J. Biol. Chem. 271, 631-634.
6. Chen Y. R., Wang X., Templeton D., Davis R. J., and Tan T. H. (1996b) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271, 31929-31936.
7. Chen Y. R., Wang W., Kong A. N. T., and Tan T. H. (1998) Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem. 273, 1769-1775.
8. DiBenedetto F. E. and Bito L. Z. (1986) Transport of prostaglandin and other eicosanoids by the choroid plexus: its characterization and physiological significance. J. Neurochem. 46, 1725-1731.
9. Gavrieli Y., Sherman Y., and Ben-Sasson S. A. (1980) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol 119, 493-501.
10. Gilman A. (1984) G proteins and dual control of adenylate cyclase. Cell 36, 577-579.
11. Greene L. A. and Shooter E. M. (1980) The nerve growth factor: biochemistry, synthesis and mechanism of action. Annu. Rev. Neurosci. 3, 353-402.
12. Hakes D. J. and Berezney R. (1991) Molecular cloning of matrin F/G: a DNA binding protein of the nuclear matrix that contains putative zinc finger motifs. Proc. Natl. Acad. Sci. USA 88, 6186-6190.
13. Ham J., Babij C., Whitfield J., Pfarr C. M., Lallemand D., Yaniv M., and Rubin L. L. (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939.
14. Jarvis W. D., Fornari F. A. Jr., Freemerman A. J., Szabo E., Birrer M. J., Johnson C. R., Barbour S. E., Dent P., and Grant S. (1997) Coordinate regulation of stress-and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52, 935-947.
15. Jones D. J. and McKenna L. F. (1980) Cyclic AMP formation in rat spinal cord tissue slices. Neuropharmacology 19, 669-674.
16. Joseph R., Li W., and Han E. (1993) Neuronal death, cytoplasmic calcium and internucleosomal DNA fragmentation: evidence for DNA fragments being released from cells. Brain Res. Mol. Brain Res. 17, 70-76.
17. Kanai N., Lu R., Satriano J. A., Bao Y., Wilkoff A. W., and Schuster V. L. (1995) Identification and characterization of a prostaglandin transporter. Science 268, 866-869.
18. 1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Neuropharmacology 36, 1023-1030.
19. 2 receptor mRNA in the rat spinal cord. Life Sci. 61, 2111-2116.
20. Kure S., Tominaga K., Yoshimoto K., Toda K., and Narisawa K. (1980) Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179, 39-45.
21. Laderoute K. R. and Webster K. A. (1997) Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ. Res. 80, 336-344.
22. Lin A., Minden A., Martinetto H., Claret F.-X., Lange-Carter C., Mercurio F., Johnson G. L., and Karin M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268, 286-290.
23. Lu R., Kanai N., Bao Y., and Schuster V. L. (1996) Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT). J. Clin. Invest. 98, 1142-1149.
24. Mackey J. P. and Crossley M. (1998) Zinc fingers are sticking together. Trends Biochem. Sci. 23, 1-4.
25. Mochizuki H., Goto K., Mori H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
26. Mu X., He J., Anderson D. W., Trojanowski J. Q., and Springer J. E. (1996) Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379-386.
27. Narumiya S., Ohno K., Fujiwara M., and Fukushima M. (1986) Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. J. Pharmacol. Exp. Ther. 239, 506-511.
28. Ohno K. and Hirata M. (1993) Characterization of the transport system of prostaglandin A2 in L-1210 murine leukemia cells. Biochem. Pharmacol. 46, 661-670.
29. Park D. S., Stefanis L., Yan C. Y. I., Farinelli S. E., and Greene L. Y. (1996) Ordering the cell death pathway. J. Biol. Chem. 271, 21898-21905.
30. Pittman R. N., Wang S., DiBenedetto A. J., and Mills J. C. (1993) A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13, 3669-3680.
31. Rossi A., Elia G., and Santoro G. (1997) Inhibition of nuclear factor κB by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 94, 746-750.
32. Schramm M. and Selinger Z. (1984) Message transmission: receptor controlled adenylate cyclase system. Science 225, 1350-1356.
33. Schulz J. B., Bremen D., Reed J. C., Lommatzsch J., Takayama S., Wüllner U., Löschmann P. A., Klockgether T., and Weller M. (1997) Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J. Neurochem. 69, 2075-2086.
34. Schuster V. L., Lu R., and Coca-Prados M. (1997) The prostaglandin transporter is widely expressed in ocular tissues. Surv. Ophthalmol. 41 (Suppl. 2), S41-S45.
35. 2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 272, 4631-4639.
36. Takadera T. and Ohyashiki T. (1997) Apoptotic cell death and caspase 3 (CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC 12 cells. Eur. J. Biochem. 249, 8-12.
37. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
38. Verheij M., Bose R., Lin X. H., Yao B., Jarvis W. D., Grant S., Birrer M. J., Szabo E., Zon L. I., Kyriakis J. M., Haimovitz-Friedman A., Fuks Z., and Kolesnick N. (1996) Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380, 75-79.
39. Weiss E. R., Hao Y., Dickerson C. D., Osawa S., Shi W., Zhang L., and Wong F. (1995) Altered cyclic AMP levels in retinas from transgenic mice expressing a rhodopsin mutant. Biochem. Biophys. Res. Commun. 216, 755-761.
40. Withers D. J., Bloom S. R., and Rozengurt E. (1995) Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J. Biol. Chem. 270, 21411-21419.
41. Xia X., Dickens M., Raingeaud J., Davis R. J., and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
42. Yankner B. A. and Shooter E. M. (1982) The biology and mechanisms of action of nerve growth factor. Annu. Rev. Biochem. 51, 845-868.
43. Yao Z., Diener K., Wang X. S., Zukowski M., Matsumoto G., Zhou G., Mo R., Sasaki T., Nishina H., Hui C. C., Tan T. H., Woodgett J. P., and Penninger J. M. (1997) Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase. J. Biol. Chem. 272, 32378-32383.